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Abstract 
  BACKGROUND: Hypertension (HTN) is one of the most important problems in all parts of the 
world. Although the disease is usually asymptomatic, its diagnosis and treatment are easy. The 
aim of this study was to compare the effect of Nifedipine (Adalat®), Captopril and sublingual 
Nitroglycerin on reducing blood pressure (BP). 
 METHODS:  This study was a parallel group randomized controlled trial. From the patients 
referred to our heart clinic, 120 patients with severe HTN were enrolled in the study. The 
patients were randomly allocated into 3 groups A, B, and C. The patients were advised to use 5 
drops of Adalat in group A, Captopril 25 mg sublingually in group B, and 1 sublingual 
Nitroglycerin pearl in group C. The BP was measured every 20 minutes during one hour. 
 RESULTS: Systolic BP was reduced significantly by Adalat and Captopril compared with 
sublingual Nitroglycerin in the 20th, 40th and 60th  minutes (P = 0.001), but there was no 
significant difference between Adalat and captopril in reducing systolic BP. In addition, the 
result of reducing diastolic BP was not significantly different among the three groups. 
  CONCLUSION: We saw the same effect on reducing BP by Captopril, Adalat, and sublingual 
Nitroglycerin. Among these three drugs, the side effects of Captopril were the least frequent. 
Adalat caused headache and flushing. Thus, it seems Captopril can be used instead of Adalat in 
medical centers. 
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Introduction 
Cardiovascular diseases are one of the most 
important causes of death in developed countries 
and Iran. Hypertension (HTN) plays the most 
important role in preventing these diseases. 
Controlling BP as a cost effective method has been 
encouraged by different references. 
  HTN crisis is a life threatening, preventable 
medical situation. It was previously divided into 
malignant and emergency HTN. Malignant HTN 
was defined as a condition in which BP rises to more 
than 180/120 mm Hg, and end organ damages 
happen. Emergency HTN is a condition in which 
BP rises to the same degree without end organ 
damages. In this condition, oral drugs should be 
administrated gradually within 24-48 hours. Also, 
malignant hypertension should be lowered during 
the first 2-4 hours. It should be reduced to 15-25% 
of the initial BP, and in other words, not less than 
100-110 mm Hg for diastolic PB.1-5  
  According to the high prevalence of uncontrolled 
HTN among outpatient,5 we aimed to compare the 
effects of three drugs, Adalat®, Captopril and 
sublingual Nitroglycerin in patients with HTN crisis 
without end organ damages. 
Materials and Methods 
Ethical Approval 
This study was conducted in Lorestan University of 
Medical Sciences (LUMS) in the autumn of 2009. The 
institutional review board of LUMS approved the 
protocol. Financial approval was signed by the 
institutional board and the costs were supported by the 
university. The aim of the study was explained to the   A. Maleki, M. Sadeghi, M. Zaman, M.J. Tarrahi, B. Nabatchi 
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patients, and written consent was obtained. All authors 
respected the Helsinki declaration during the study. 
Study Design 
This study was a parallel group, randomized control 
trial. One hundred and twenty patients were randomly 
allocated to three groups (40 cases in each group). For 
randomization process, all the cases were enrolled in a 
randomizing table which minimizes the effects of bias 
and confounding factors on the results. Allocation 
concealment was accomplished by putting the names 
of the drugs in the numbered opaque sealed envelopes. 
A trained nurse who did not know the group of each 
patient, measured patients' BP by means of a standard 
sphygmomanometer first when the patient referred to 
the hospital (before taking the drugs) and then in the 
20th, 40th and 60th minutes after drug administration. 
Also, the drugs were administered by a nurse who did 
not know the group of each patient. Five droplets of 
sublingual Nifedipine (Adalat®) were taken by group A. 
Captopril, 25 mg sublingually, was prescribed for group 
B and sublingual Nitroglycerin (glyceryl trinitrate) was 
prescribed for group C. Characteristic data and the BP 
were recorded in a checklist.  
Participants 
For our study, 120 patients with a systolic BP ranged 
from 180-210 mm Hg and a diastolic BP ranged from 
110-120 mm Hg were enrolled. The inclusion criteria 
included severe HTN without cardiac symptoms and 
normal neurologic and fundoscopic examinations. 
  The exclusion criteria included the presence of 
chest pain, dyspnea, headache and decreased level 
of consciousness. 
Data Analysis 
We compared the frequency of reduced systolic and 
diastolic BP with each of the drugs, Adalat®, 
Captopril or sub lingual Nitroglycerin. For this 
purpose, we used Pearson X2 test. For comparing the 
mean percentage of BP among the three groups, we 
used ANOVA test. A P<0.05 was considered 
significant. For statistical analysis, we used the SPSS 
software, version 16. 
Results 
The mean age was 61.2 years old in group A, 
58.3years old in group B and 63years old in group C. 
From 40 patients in each group, 16 in group A, 18 in 
group B and 20 in group C were men. 
  We found that Adalat was effective on reducing 
systolic BP and the results were significantly different 
than those before using the drug (P < 0.001). Systolic 
BP was reduced by 16% in the 20th, by 24% in the 
40th and by 28% in the 60th minutes by Adalat.  
  Captopril was significantly effective on reducing 
systolic BP (P < 0.001). Captopril reduced BP by 17% 
in the 20th, by 22.5% in the 40th, and by 27.6% in the 
60th minutes (Table 1). 
  In the third group, sublingual Nitroglycerin was 
also significantly effective on reducing systolic BP   
(P < 0.001). The reduction rate by sublingual 
Nitroglycerin was 10.5 % in the 20th, 17% in the 40th, 
and 20% in the 60th minutes (Figure 1).  
  We used ANOVA test to compare reduction rate 
among three groups. Although, the results of systolic 
BP were significantly different among group A, B and 
C, the results were not significantly different for 
diastolic BP.  
  Comparing the reduced systolic BP after using 
Adalat in group A and C revealed a significant P value 
(0.001), but the comparison didn’t reveal significant 
differences between the group who used Captopril 
with the one who used Adalat. 
Discussion 
By our investigation, there was a significant reduction 
of BP by Adalat, Captopril and Nitroglycerin, but the 
reduction rate was more remarkable by using Adalat® 
and Captopril. 
 
Table 1. Comparing the differences between initial and secondary systolic BP after using each drug. 
In the 60
th minutes 
after using the drug 
In the 40
th minutes 
after using the drug 
In the 20
th minutes 
after using the drug  Initial BP  Time 
 
Index  N  C  A  N  C  A  N  C  A  N
***  C
**  A
* 
150  142  143  156  153  152  170  163  167  190  198  200  The Mean Systolic BP 
(mm Hg) 
20  27.6  28  17  22.5  24  10.5  17  16  0  0  0 
Mean Percentage of 
Differences between 
before and after using 
the drug (%) 
*Adalat  
**Captopril  
***Sublingual Nitroglycerin 
 Drugs in reducing blood pressure 
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Figure 1. The comparison between the mean systolic BP variations in the 20th, 40th and 60th minutes 
of taking each of the drugs in group A, B and C. 
 
  Different protocols have been announced for 
management of HTN crisis by recent articles. 
Among them, intravenous therapy by sodium 
nitroprusside, Nitroglycerin or Labetalol after oral 
therapy was recommended by Ardigo S, et al. in 
2008.6 In 2009, BP monitoring after intravenous 
therapy for emergent types and oral medications for 
urgent situations were recommended.5 
  Previous similar studies about the efficacies of oral 
drugs in patients with HTN crises were not paid 
attention in Iran. So, we designed our study to compare 
the effects of Adalat®, Captopril and Nitroglycerin on 
decreasing BP in patients with severe HTN.   
  In the last two decades, differences between 
Captopril and Nifedipine were frequently studied. 
  The results of the articles about reducing BP are 
almost the same; thus, the protocol should be 
suggested by considering the patients’ conditions. For 
instance, Captopril should not be prescribed for 
patients with bilateral renal artery stenosis. In patients 
with ischemic heart diseases it is important to note 
that dihydropyridins such as Nifedipine increase the 
heart rate whereas clonidine, beta-blockers and 
labetalol decrease the heart rate. In patients with acute 
coronary attacks, (10 mg sublingually) are the two 
most efficient drugs for reducing BP in patients with 
severe HTN. With the purpose of finding the effect 
of these drugs, lots of studies have been designed 
Nitroglycerin is recommended.3 
  Captopril (25mg sublingually) and Nifedipine since 
1990. Guerrera G, et al. showed a remarkable 
decrease in BP after 10 minutes of using Captopril 
while the maximum efficacy was seen after 30 
minutes. Although the effect of Nifedipine began 
within 5 minutes, the peak of effect appeared after 20 
m inutes. Except a dela yed onset of eff ect b y usi ng 
Captopril in comparison with Nifedipine, they didn’t 
find significant difference between the drugs in 
decreasing BP.7 In the next year, Schneider E, et al. 
compared the effect of Captopril and Nifedipine and 
their combination for emergent HTN. By their 
findings, BP was decreased more rapidly in the first 
60 minutes by Nifedipine in comparison with other 
drugs, but the result was the same after 240 minutes. 
Using the two drugs, Nifedipine and Captopril, 
together reduced BP the most.8 In 1993, Dadkar VN 
et al. designed a study with the same dosages of 
Nifedipine and Captopril. Their result was 
approximately in accordance with Guerrera G, et al. 
in 1990 but they saw earlier onset of effect, more 
effective response and longer duration of response in 
patients who used Nifedipine in comparison with 
Captopril.9 In 1996 a study compared the efficacy of 
Nifedipine, Captopril and Nifedipine with Metoprolol 
in hypertensive crisis. By their results, the drugs 
affected within 5 minutes except Captopril which was 
effective after 15 minutes. In their studies, Nifedipine 
caused some side effects such as flushing and 
Captopril caused heaviness of head.10 In 1996, 
sublingual drugs were examined for rapid lowering BP 
and Captopril, Adalat® and Nitroglycerin were 
suggested.2 In 1996, it was seen that the drugs were   A. Maleki, M. Sadeghi, M. Zaman, M.J. Tarrahi, B. Nabatchi 
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more effective when used above the tongue than 
sublingual forms.2,11  
  By considering previous studies and this trial, oral 
drugs are recommended to be used in patients with 
HTN crisis without any fears of undesirable side 
effects. It is noted that Captopril is completely 
forbidden during pregnancy. Regarding the Joseph 
Varon speech in 2009, due to the side effects of 
Nifedipine and Nitroglycerin, these drugs are not 
desirable choices for the first line therapy in patients 
with HTN crises.12 
Conclusion 
According to the previous studies and also our study, 
because of the same effect of Captopril and Adalat® on 
reducing BP and the side effects of Adalat®, Captopril is 
more recommended to be used in patients with HTN 
crisis without end organ damages. 
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